{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:48:34Z","timestamp":1758440914034,"version":"3.44.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.mcna.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T20:45:56Z","timestamp":1666385156000},"page":"971-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in Evaluation and Treatment of Severe Asthma (Part One)"],"prefix":"10.1016","volume":"106","author":[{"given":"Christopher H.","family":"Fanta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2022.08.003_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1164\/arrd.1985.131.4.599","article-title":"Damage of airway epithelium and bronchial reactivity in patients with asthma","volume":"131","author":"Laitinen","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.mcna.2022.08.003_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1164\/ajrccm\/142.2.434","article-title":"Mucosal inflammation in asthma","volume":"142","author":"Djukanovic","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.mcna.2022.08.003_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1164\/ajrccm.158.2.9705036","article-title":"Inflammatory cell distribution within and along asthmatic airways","volume":"158","author":"Haley","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJM199108083250603","article-title":"Comparison of a \u03b22-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma","volume":"325","author":"Haahtela","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib5","first-page":"877","article-title":"Inhaled steroids and the risk of hospitalization for asthma","volume":"277","author":"Donahue","year":"1997","journal-title":"J\u00a0Amer Med Assoc"},{"key":"10.1016\/j.mcna.2022.08.003_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM200008033430504","article-title":"Low-dose inhaled corticosteroids and the prevention of death from asthma","volume":"343","author":"Suissa","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib7","first-page":"425","article-title":"Guidelines for the diagnosis and management of asthma: National Heart, Lung and Blood Institute. National Asthma Education Program - Expert Panel Report","volume":"88","author":"Sheffer","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"No. SS-5","key":"10.1016\/j.mcna.2022.08.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7005a1","article-title":"Asthma Surveillance \u2014 United States, 2006\u20132018","volume":"70","author":"Pate","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.mcna.2022.08.003_bib9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1056\/NEJM199211123272004","article-title":"A\u00a0comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma","volume":"327","author":"Pearlman","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma","volume":"337","author":"Pauwels","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol","volume":"129","author":"Nelson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.mcna.2022.08.003_bib12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1056\/NEJMoa1511049","article-title":"Serious asthma events with fluticasone plus salmeterol versus fluticasone alone","volume":"374","author":"Stempel","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1056\/NEJMoa1511190","article-title":"Serious asthma events with budesonide plus formoterol vs. budesonide alone","volume":"375","author":"Peters","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaci.2018.10.065","article-title":"Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate","volume":"143","author":"Weinstein","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2022.08.003_bib15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","volume":"146","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2022.08.003_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/thoraxjnl-2013-204114","article-title":"The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry","volume":"70","author":"O\u2019Neill","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.mcna.2022.08.003_bib19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and difficult-to-treat asthma in adults","volume":"377","author":"Israel","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mcna.2022.08.003_bib21","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1164\/ajrccm.162.6.ats9-00","article-title":"Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions","volume":"162","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of severe asthma worldwide: data from the International Severe Asthma Registry","volume":"157","author":"Wang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.mcna.2022.08.003_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1164\/ajrccm\/146.4.888","article-title":"A\u00a0community-based study of the epidemiology of asthma: incidence rates, 1964-1983","volume":"146","author":"Yunginger","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.mcna.2022.08.003_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.otc.2013.08.014","article-title":"Paradoxic vocal fold movement disorder","volume":"47","author":"Matrka","year":"2014","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.mcna.2022.08.003_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/thorax.58.7.561","article-title":"Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol","volume":"58","author":"Heaney","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.mcna.2022.08.003_bib26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1183\/09031936.03.00017003","article-title":"Systematic assessment of difficult-to-treat asthma","volume":"22","author":"Robinson","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mcna.2022.08.003_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2016.19627","article-title":"Reevaluation of diagnosis in adults with physician-diagnosed asthma","volume":"317","author":"Aaron","year":"2017","journal-title":"J\u00a0Amer Med Assoc"},{"key":"10.1016\/j.mcna.2022.08.003_bib28","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM199705083361904","article-title":"The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma","volume":"336","author":"Rosenstreich","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib29","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJMoa032097","article-title":"Results of a home-based environmental intervention among urban children with asthma","volume":"351","author":"Morgan","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anai.2021.03.011","article-title":"Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma","volume":"127","author":"Epstein","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.mcna.2022.08.003_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2008.10.062","article-title":"Exposure to traffic: lung function and health status in adults with asthma","volume":"123","author":"Balmes","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2022.08.003_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1513\/AnnalsATS.202001-046ST","article-title":"Outdoor air pollution and new-onset airway disease. An official American Thoracic Society workshop report","volume":"17","author":"Thurston","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.mcna.2022.08.003_bib33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.mcna.2022.08.003_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1753465810384606","article-title":"The relationship between gastroesophageal reflux and asthma: an update","volume":"5","author":"McCallister","year":"2011","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.mcna.2022.08.003_bib35","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa0806290","article-title":"Efficacy of esomeprazole for treatment of poorly controlled asthma","volume":"360","author":"American Lung Association Clinical Research Centers","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib36","doi-asserted-by":"crossref","first-page":"e043860","DOI":"10.1136\/bmjopen-2020-043860","article-title":"Randomised trials of proton pump inhibitors for gastro-oesophageal reflux disease in patients with asthma: an updated systematic review and meta-analysis","volume":"11","author":"Zheng","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.mcna.2022.08.003_bib37","article-title":"Obesity and asthma","author":"Dixon","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib38","doi-asserted-by":"crossref","first-page":"190003","DOI":"10.1183\/16000617.0003-2019","article-title":"Bariatric surgery: a potential cure for asthma?","volume":"28","author":"Chaaban","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.mcna.2022.08.003_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00216013","article-title":"The clinical and genetic features of COPD-asthma overlap syndrome","volume":"44","author":"Hardin","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mcna.2022.08.003_bib40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMra1411863","article-title":"The asthma-COPD overlap syndrome","volume":"373","author":"Postma","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib41","first-page":"97","article-title":"Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient","volume":"32","author":"Odeh","year":"1991","journal-title":"J\u00a0Fam Pract"},{"key":"10.1016\/j.mcna.2022.08.003_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/PPA.S234651","article-title":"Understanding patient perspectives on medication adherence in asthma: a targeted review of qualitative studies","volume":"14","author":"Amin","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.mcna.2022.08.003_bib43","first-page":"384.e1","article-title":"Inhaled corticosteroids and voice problems. What is new?","volume":"31","author":"Spantideas","year":"2017","journal-title":"J\u00a0Voice"},{"key":"10.1016\/j.mcna.2022.08.003_bib44","first-page":"281","article-title":"Concerning the nature of intolerance to aspirin","volume":"40","author":"Samter","year":"1967","journal-title":"J\u00a0Allergy"},{"key":"10.1016\/j.mcna.2022.08.003_bib45","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease \u2013 new prime suspects","volume":"374","author":"Laidlaw","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2020.10.043","volume":"147","author":"Stevens","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2022.08.003_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2500\/aap.2019.40.4262","article-title":"Allergic bronchopulmonary aspergillosis","volume":"40","author":"Patel","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.mcna.2022.08.003_bib49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A\u00a0randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib50","doi-asserted-by":"crossref","first-page":"2101787","DOI":"10.1183\/13993003.01787-2021","article-title":"A\u00a0randomized trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"59","author":"Agarwal","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mcna.2022.08.003_bib51","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jaip.2020.03.023","article-title":"Mepolizumab for allergic bronchopulmonary aspergillosis: report of 20 cases from the Belgian severe asthma registry and review of the literature","volume":"8","author":"Schleich","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.mcna.2022.08.003_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2016.11.019","article-title":"Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature","volume":"122","author":"Li","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib53","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis, and periarteritis nodosa","volume":"27","author":"Churg","year":"1951","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mcna.2022.08.003_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/1744666X.2019.1697678","article-title":"Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of disease","volume":"16","author":"Berti","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.mcna.2022.08.003_bib55","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.116.1.266-a","article-title":"Zafirlukast and Churg-Strauss syndrome","volume":"116","author":"Wechsler","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.mcna.2022.08.003_bib56","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1164\/rccm.200409-1181PP","article-title":"Severe asthma in adults","volume":"172","author":"Wenzel","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2500\/aap.2012.33.3583","article-title":"Assessment and management of difficult asthma: part 1","volume":"33","author":"Long","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.mcna.2022.08.003_bib59","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib60","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1164\/rccm.202109-2093ST","article-title":"Use of fractional exhaled nitric oxide to guide the treatment of asthma: an official American Thoracic Society clinical practice guideline","volume":"204","author":"Khatri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib61","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/thx.2009.124925","article-title":"Exhaled nitric oxide thresholds associated with a sputum eosinophil count\u00a0>3% in a cohort of unselected patients with asthma","volume":"65","author":"Schleich","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.mcna.2022.08.003_bib62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rmed.2018.09.014","article-title":"Validation of ATS clinical practice guideline cut-points for FeNO in asthma","volume":"144","author":"Jeppegaard","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib63","doi-asserted-by":"crossref","first-page":"106013","DOI":"10.1016\/j.rmed.2020.106013","article-title":"Should we consider paranasal and chest computed tomography in severe asthma patients?","volume":"169","author":"Zamarron","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.mcna.2022.08.003_bib64","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1378\/chest.127.3.984","article-title":"Tracheomalacia and tracheobronchomalacia in children and adults: an in-depth review","volume":"127","author":"Carden","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.mcna.2022.08.003_bib65","first-page":"169","article-title":"Induced sputum for the investigation of airway inflammation: evidence for its clinical application","volume":"6","author":"Hargreave","year":"1999","journal-title":"Can Respir J"},{"key":"10.1016\/j.mcna.2022.08.003_bib66","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon consensus","volume":"67","author":"Gyawali","year":"2018","journal-title":"Gut"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:46:50Z","timestamp":1758419210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712522000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0025712522000967"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2022.08.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"type":"print","value":"0025-7125"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Evaluation and Treatment of Severe Asthma (Part One)","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}